"Other companies write that their test accuracy is 99.9%, so what is the percentage for IDENSIL?"I am Saito, representative ...
The National Science Foundation launched a $30 million, five-year project through the new Center for Genome Intelligence ...
Identifai Genetics (ASX:IDG) is heading for an ASX listing with a US$2.2m loss, a US$1m cash balance, and a prenatal test ...
There are probably thousands of individuals out there who need to be retested,” said Dr. Sofia Merajver, a breast cancer ...
Women who had genetic testing for inherited cancer risk years ago may want to ask about testing again, experts say.
Most patients with BRCA1/2 pathogenic variants who received navigation for cascade genetic testing completed genetic testing by 18 months.
Medicinal Genomics launches next-day qPCR pathogen testing for dietary supplements, independently validated as equivalent to USP <2022> plating.
Ambry Genetics launches GenomeNext and GenomeReveal, whole genome sequencing solutions for diagnosing patients with rare ...
Prioritize NGS, liquid biopsy, AI-driven interpretation and strategic partnerships to capitalize on precision oncology, companion diagnostics and early detection.Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) ...
Women who had genetic testing for inherited cancer risk years ago may want to ask about testing again, experts say. A ...
(NASDAQ: TEM), today announced the launch of GenomeNext™ and GenomeReveal™, a comprehensive whole genome sequencing (WGS) ...
Ambry Genetics, a wholly owned subsidiary of Tempus AI (NASDAQ:TEM), has introduced GenomeNext and GenomeReveal, a new whole genome sequencing solution designed to improve the identification of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results